RecruitingNCT06880718
Brixadi or Sublocade during transition out of prison
About this title
Read the official source — NCT06880718Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
The protocol includes: Completing questionnaires.
- Listed locations
- CranstonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 18, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Lifespan
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06880718
- Official title
Show the full official title
Injectable Buprenorphine During Transition Out of Prison: A Partially Randomized Preference Pilot Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Cranston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lifespan.
Does this study involve medication?
Yes. The study involves medication, including Brixadi (Injectable Buprenorphine) and Sublocade.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
